FCS: Enhancing the Diagnosis
Daniel Gaudet, MD, PhD
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Latest Clinical Trial Outcomes and Breakthroughs for FCS
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Jan T. Kielstein, MD, FASN, FERA
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Riccardo Maria Inciardi, MD, PhD
Cristina Gavina, MD, PhD
Giuseppe Galati, MD
Echocardiographic workup for HCM – making the diagnosis and evaluation of cardiac function
Thor Edvardsen, MD, PhD
Role of echocardiography in risk stratification and treatment decision-making
Maurizio Pieroni, MD, PhD
Echo essentials for HCM: The heartbeat of diagnosis and treatment
Elena Arbelo, MD, PhD
Understanding hypertrophic cardiomyopathy and recent guidelines
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Valeria Caso, MD, PhD
Patient Case Study: Obesity
Renato D. Lopes, MD, MHS, PhD
Optimizing AAV Outcomes: Maintenance Therapies
Silke R. Brix, MD, MRCP, SCPR
Patient Case Study: Elderly
Elevating Care for Patients With Severe Renal Disease in AAV
Patient Case Study: Obesity and VTE
Alexander T. Cohen, MD, MBBS
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.